Sen. Wyden Continues Investigation Into Big Pharma Tax Practices
April 05, 2022
April 05, 2022
WASHINGTON, April 5 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on April 4, 2022:
Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation into Big Pharma's tax practices, and how loopholes in the tax code have allowed large multinational corporations headquartered in the U.S. to further abuse tax havens and avoid paying U.S. taxes on prescription drug sales. While U.S. sales account for 46 perce . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation into Big Pharma's tax practices, and how loopholes in the tax code have allowed large multinational corporations headquartered in the U.S. to further abuse tax havens and avoid paying U.S. taxes on prescription drug sales. While U.S. sales account for 46 perce . . .